Oxysterol-binding protein (ORP) related proteins, including ORP7, play crucial roles in cellular lipid metabolism and homeostasis. They belong to a family of intracellular lipid receptors known for their ability to bind to and transfer lipids between cellular membranes. The significance of ORP7, as with other members of this family, lies in its capacity to regulate the intracellular movement and distribution of lipids, such as cholesterol and phospholipids. Proper functioning of proteins like ORP7 ensures that cells maintain a balance in lipid levels, facilitating various cellular processes like membrane trafficking, signal transduction, and lipid metabolism. Dysregulation or malfunctioning of these proteins could, in theory, result in perturbations in lipid homeostasis, leading to cellular dysfunction.
The inhibitors targeting ORP7 and similar proteins are chemicals that modulate the activity of these lipid transport proteins. These inhibitors could work by directly binding to the protein, thereby blocking its lipid-binding site or altering its conformation. Another mode of action could be through the modulation of the cellular lipid environment, affecting the availability or accessibility of the lipids that ORP7 handles. For example, some inhibitors might disrupt the cellular cholesterol homeostasis, thus indirectly impacting the function of ORP7. Other inhibitors could alter the membrane dynamics or fluidity, which would in turn influence the lipid transfer capabilities of ORP7. By hindering ORP7's ability to interact with, bind to, or transport lipids, these inhibitors can effectively modulate the intricate balance of intracellular lipid levels and dynamics, ultimately affecting various cellular processes that are dependent on lipid homeostasis. The precise mechanism and the degree of inhibition can vary widely among the class of ORP7 inhibitors, each offering a unique approach to regulating lipid dynamics in the cell.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $52.00 $89.00 $166.00 $465.00 | 8 | |
This oxysterol binds to certain OSBP-related proteins, modulating lipid transport. The altered lipid homeostasis could indirectly affect ORP7's lipid-handling function, potentially altering its activity. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $140.00 $500.00 | 2 | |
U18666A induces intracellular cholesterol accumulation, perturbing cholesterol transport. This could impinge upon ORP7's functional integration with cholesterol dynamics, altering its normal operations. | ||||||
GW 3965 hydrochloride | 405911-17-3 | sc-224011 sc-224011A sc-224011B | 5 mg 25 mg 1 g | $137.00 $474.00 $3060.00 | ||
As an LXR agonist, GW3965 can influence cellular oxysterol levels. Elevated oxysterols might modify the lipid-binding behavior of ORP7, affecting its standard function. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $26.00 $34.00 | 20 | |
Neomycin disrupts lipid interactions which could impede ORP7's lipid-binding capacities, potentially affecting its role in lipid homeostasis and transport. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $51.00 $292.00 | 3 | |
Progesterone influences cholesterol synthesis. This alteration in cholesterol levels might affect ORP7's lipid interactions, modifying its regular activity. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase, impacting cholesterol synthesis. ORP7, being involved in lipid dynamics, might experience functional modulation due to changes in cholesterol concentrations. |